Nishadil
Signup Signin
Delhi | 25°C (windy)
Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering

Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering
Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development

Eupraxia Pharmaceuticals Secures $70 Million Through Public Offering to Accelerate Osteoarthritis Treatment Development
Adial Pharmaceuticals Soars: FDA's Positive Feedback Fuels Hope for Groundbreaking AUD Treatment

Adial Pharmaceuticals Soars: FDA's Positive Feedback Fuels Hope for Groundbreaking AUD Treatment
Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer

Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer
Load more..